Histogen Inc
NASDAQ:HSTO
Histogen Inc
Revenue
Histogen Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Histogen Inc
NASDAQ:HSTO
|
Revenue
$30k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-76%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Histogen Inc
Revenue Breakdown
Breakdown by Geography
Histogen Inc
Breakdown by Segments
Histogen Inc
Total Revenue:
3.8m
USD
|
License:
3.8m
USD
|
See Also
What is Histogen Inc's Revenue?
Revenue
30k
USD
Based on the financial report for Sep 30, 2023, Histogen Inc's Revenue amounts to 30k USD.
What is Histogen Inc's Revenue growth rate?
Revenue CAGR 5Y
-76%
Over the last year, the Revenue growth was -99%.